TransNusa To Operate Additional Frequencies for Both Singapore-Jakarta and Singapore-Bali Routes- Additional frequencies respond to strong demand for travel between Indonesia and Singapore while strengthening regional connectivity- Both routes received additional scheduled flight slots, providing TransNusa passengers options for day travel- TransNusa increases its minimum baggage allowance to 20kgs, in addition to the 7kg hand carry for it’s minimum package bundle, SEAT, and increased minimum baggage allowance to 30kgs for its highest bundle, Flexi-ProJAKARTA, Mar 25, 2026 - (ACN Newswire via SeaPRwire.com) - PT TransNusa Aviation Mandiri (TransNusa) today announced the launch of additional scheduled flights between Jakarta and Singapore as well as Jakarta and Bali, further strengthening connectivity between two of Southeast Asia’s paramount business and tourism travel hubs.TransNusa Group Chief Executive Officer, Datuk Bernard Francis said that the additional scheduled flight between Soekarno–Hatta International Airport in Jakarta and Singapore Changi Airport will start on April 17 while the additional flight from Gusti Ngurah Rai International Airport in Bali to Changi Airport will start on May 2. Sale of tickets for both additional scheduled flights started on March 17 and can be bought directly from transnusa.co.id or on any main online travel agency platform.The additional flights are part of the TransNusa’s broader strategy to expand regional connectivity and respond to the growing demand for travel between Indonesia and Singapore—two markets with strong economic, cultural, and tourism ties.“Singapore is one of the region’s vital aviation and commercial hub, and these additional flights will provide travellers with greater flexibility while supporting trade and tourism between the two countries,” Datuk Bernard added.“The Jakarta–Singapore corridor is one of the busiest international routes in the region, serving millions of travellers each year. By increasing capacity on this route, we aim to provide a more seamless connections for passengers traveling across Southeast Asia and beyond,” Datuk Bernard stressed, adding that TransNusa’s passengers will benefit from improved scheduling options, allowing for easier same-day connections to a wider network of destinations.“Our goal is to continue improving accessibility across Southeast Asia by increasing frequencies on high-demand routes,” explained Datuk Bernard.Flight DetailsTransNusa’s additional scheduled flight, 8B 155, will depart Jakarta at 07.45pm from Soekarno-Hatta International Airport in Jakarta and arrive at the Singapore Changi Airport at 10.25pm. The flight, 8B 156, will depart Singapore Changi Airport at 11.20pm and arrive at Soekarno-Hatta International Airport in Jakarta at 12.10am.With the launch of this news additional Frequency, TransNusa will be operating three daily flights from Jakarta to Singapore effective April 17, 2026.On the Bali-Singapore route, TransNusa's new scheduled flight, 8B 553, will depart the Gusti Ngurah Rai International Airport at 10.20am and arrive at Changi Airport at 01.15pm. Meanwhile, TransNusa’s flight, 8B 554, will depart Changi Airport at 02.15pm and arrive back at the Gusti Ngurah Rai International Airport in Bali at 05.55pm.TransNusa will be utilising its Airbus A320 for both the international routes.TransNusa, which aims to ensure its passengers travel with ease and comfort, has configured its A320 aircrafts with a 174-seat configuration, which allows for passengers to enjoy about 30 inches of legroom, comparable to the experience passengers would get in a full-service airline."We are committed to providing affordable and competitive ticket prices, while still providing premium services to our customers,” stressed Datuk Bernard.For its international flights, TransNusa not only provides premium services with competitive ticket prices, but the airline also has attractive product bundles called SEAT, SEAT-PLUS and FLEXI-PRO."Our SEAT passengers will now enjoy check-in baggage of 20kgs,” Datuk Bernard said, explaining that the baggage offering was over and above the 7kgs limit offered as a passenger’s hand carry.“For the highest package, FLEXI-PRO, we have increased our baggage allowance to 30kgs, free to choose seats, free food, and drinks, and priority boarding. In addition, TransNusa also provides its FLEXI-PRO passengers with the flexibility to change their flight schedule without restrictions and obtain refund when needed,” concluded Datuk Bernard.About TransNusaTransNusa Airline, is a Premium Service Carrier. In February 2024, the airline rebranded itself to a Premium Service Carrier in line with its upgraded aircrafts that offers better comfort as well as based on the flexibility and quality of the services offered. TransNusa, which received its AOC certification on 9th September 2022, launch its first three A320 operations on 6th October, 14th October and 12th December, 2022.In 2023, TransNusa introduced a new business model making it the first Premium Service Carrier in the Asia Pacific region. TransNusa introduced its first international flight on 14th April, 2023. The airline is currently based in Jakarta and Bali.On the international front, TransNusa flies to Singapore, Guangzhou, Kuala Lumpur, Perth, Shanghai, and Shenzhen. The airline became the second Indonesian airline to fly to China and the first Indonesian airline to launch a Premium Service Carrier business model. Passengers can book their flights on the TransNusa website at www.transnusa.co.id, through any secure online travel agent, through authorized travel agents in Singapore and Indonesia.Primary International Media ContactTrina Thomas RajMobile: +6012 4992672E-mail: trina@myqaseh.org Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

CLEVELAND, Ohio, Mar 26, 2026 - (ACN Newswire via SeaPRwire.com) - Formerra, a leader in performance materials distribution, announced the implementation of a transportation surcharge to address continued cost escalation across the Americas freight and logistics market. Beginning April 1, 2026, a $350 per delivery surcharge will apply to all shipments.The freight and logistics market continues to experience elevated costs driven by rising diesel prices, evolving regulatory requirements affecting driver availability, tighter trucking capacity, and increasing operating expenses across the logistics sector. Industry forecasts indicate these pressures will persist for the foreseeable future."Maintaining reliable service for our customers requires us to adapt to sustained shifts in the transportation landscape," said Tom Kelly, Formerra CEO. "This surcharge is necessary to address these industrywide cost pressures that are outside of our control while continuing to provide the high service levels customers expect from Formerra."Customers should contact their Formerra representative for more information.About FormerraFormerra is a preeminent distributor of engineered materials, connecting the world's leading polymer producers with thousands of OEMs and brand owners across healthcare, consumer, industrial, and mobility markets. Powered by technical and commercial expertise, it brings a distinctive combination of portfolio depth, supply chain strength, industry knowledge, service, leading e-commerce capabilities, and ingenuity. The experienced Formerra team helps customers across multiple industries to design, select, process, and develop products in new and better ways - driving improved performance, productivity, reliability, and sustainability. To learn more, visit www.formerra.com.Media ContactJackie MorrisFormerraMarketing Communications Managerjackie.morris@formerra.com+1 630-972-3144SOURCE: Formerra Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Toronto, ON, Mar 25, 2026 - (ACN Newswire via SeaPRwire.com) - Aleen Inc. (CSE: ALEN-U), a digital wellness company, has introduced a new data layer within its Personal Wellness Account, designed to enhance how its AI assistant interprets and structures wellness data.As part of its ongoing product development, Aleen Inc. has implemented a biomarker extraction approach that enables the system to process user-provided data and identify key indicators in a more structured way. This includes the use of a dedicated AI agent that processes documents page by page and extracts relevant biomarkers from wellness data sources.In addition to extraction, Aleen Inc. is developing a standardized structure for each biomarker, including its name, value, unit of measurement, and reference range. These structured data elements are now reflected within the Personal Wellness Account interface. Users will be able to view the total number of detected biomarkers and potential deviations directly within the file list, while a dedicated “Biomarkers” tab in the detailed view provides expanded access to the data in both table and panel formats, along with search and filtering capabilities.This development represents a step toward more structured data environments within Aleen’s ecosystem, supporting improved organization, accessibility, and interaction with wellness data. The introduction of this layer may also contribute to future enhancements in how the system identifies patterns and supports user-centered insights. This update reflects Aleen Inc.’s continued focus on building scalable data architecture and advancing its Personal Wellness Account as a structured, AI-assisted environment for working with wellness data.About Aleen Inc.Aleen Inc. operates as a digital wellness and well-being insights company. Its platform transforms personal wellness information into simple, personalized insights that promote greater self-awareness and balance in daily life. Aleen’s mission is to empower individuals with knowledge and clarity through responsible use of technology and data.For more information, visit www.aleen.ca.Forward-Looking StatementThis press release contains forward-looking statements regarding future plans and developments by Aleen Inc. These statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially. Aleen Inc. undertakes no obligation to update or revise these statements except as required by law. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Mar 25, 2026 - (ACN Newswire via SeaPRwire.com) - On March 25, 2026, Hengrui Pharma (600276.SH; 01276.HK) announced robust financial results for the full year 2025, fueled by its dual strategy of innovation and globalization. Revenue increased 13.02% year-on-year to RMB 31.63 billion, and net profit attributable to shareholders increased by 21.69% to RMB 7.71 billion.Innovation remained the engine of Hengrui’s growth: Innovative drug sales increased by 26.09% year-on-year to RMB 16.34 billion, contributing 58.34% to total drug sales. This was driven by a robust pipeline across therapeutic areas, with oncology products contributing RMB 13.24 billion in revenue (+18.52% YoY), and non-oncology products contributing RMB 3.10 billion in revenue (+73.36% YoY).Hengrui kept innovation at its core, with R&D expenditure reaching RMB 8.72 billion in 2025, accounting for 27.58% of total revenue, of which RMB 6.96 billion was expensed. During the year, the company secured seven approvals for Class 1 innovative drug, one for a Class 2 innovative drug, and six for new indications of marketed innovative drugs. The pace of regulatory progress accelerated with 15 NDA/BLAs accepted by the NMPA. Meanwhile, 28 drug candidates entered Phase III clinical trials, 61 progressed to Phase II, and 28 NMEs entered Phase I for the first time.The company currently has over 100 proprietary innovative products in clinical development and is conducting more than 400 clinical trials. This robust portfolio will be further supported by approximately 53 innovative product and indication approvals anticipated during 2026-2028.2025 marked another year of accelerated progress in Hengrui's global expansion. Licensing revenue rose 25.62% to RMB 3.39 billion, cementing the growing global recognition and value of the company’s innovative portfolio. During the year, the company completed five overseas business development transactions for innovative drugs with leading MNCs and biotechs, highlighted by a strategic collaboration with GSK. In parallel, the company continued to advance its self-developed assets and global regulatory efforts. Multiple innovative drugs had their first global clinical trials initiated, ranging from Phase I to III.Additionally, Hengrui successfully listed on the Hong Kong Stock Exchange, raising total gross proceeds of HK$11.4 billion (US$1.5 billion), including the over-allotment option — marking the largest pharmaceutical IPO in Hong Kong in the past five years and further strengthening its access to global capital.Looking ahead, Hengrui will continue to focus on addressing unmet clinical needs with its differentiated innovative portfolio, placing equal emphasis on independent R&D and open collaboration to expand access to innovative drugs for patients worldwide.About Hengrui PharmaHengrui Pharma is an innovative, global pharmaceutical company dedicated to the research, development and commercialization of high-quality medicines to address unmet clinical needs. Its therapeutic areas of focus include oncology, metabolic and cardiovascular diseases, immunological and respiratory diseases, and neuroscience. Driven by a patient-focused philosophy since its founding in 1970, Hengrui Pharma remains committed to advancing human health by striving to conquer diseases, improve health, and extend lives through the power of science and technology.Forward-Looking StatementsThis press release contains forward-looking statements, including statements about the company's future growth prospects and pipeline potential. These statements are based on current expectations and assumptions and do not guarantee future performance. Actual results, developments, and business decisions may differ materially from these forward-looking statements. All information in this press release is as of the date of this press release, and Hengrui undertakes no duty to update such information unless required by law. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Mar 25, 2026 - (ACN Newswire via SeaPRwire.com) - Everbright Grand China Assets Limited, a property leasing, property management and sales of properties held for sale company under China Everbright Group ("Everbright Grand China Assets" or the "Group", Hong Kong Stock Exchange stock code: 3699) today announced the annual results for the year ended 31 December 2025 (the "Year under Review").During the Year under Review, the Group's revenue was approximately RMB49.9 million (2024: approximately RMB45.9 million), representing a increase of approximately 8.7% as compared to last year, mainly attributable to the increase in total rental income from investment properties. The profit attributable to equity shareholders of the Company amounted to approximately RMB19.5 million (2024: approximately RMB25.3 million), representing an decrease of approximately 22.9% as compared to last year. The decrease in profit was primarily due to the increase in dividend withholding tax and deferred tax expenses recognised in 2025. The Board has proposed to pay a final dividend of RMB1.04 cents per share for the year ended 31 December 2025 (2024: RMB1.05 cents). Together with the interim dividend of RMB0.73 cents per share, the full year dividend amounts to RMB1.77 cents per share (2024: RMB2.17 cents per share).As at 31 December 2025, the Group had current assets of approximately RMB241.0 million (2024: approximately RMB239.9 million). The increase in current assets was mainly a result of [the increase in deposits with maturity of more than three months and cash and bank balances during the year].. The Group had current liabilities of RMB20.1 million (2024: approximately RMB19.9 million). The increase in current liabilities was mainly due to he rise in lease liabilities arising from lease renewals.Property LeasingDuring the year under Review, the rental income from the Group’s property leasing business was approximately RMB34.0 million for the year ended 31 December 2025 (2024: RMB30.5 million). Due to increase in the average rent per square metre, and together with rental subsidies offered to tenants, the total rental income increase. As at 31 December 2025, the Group’s property portfolio comprises three commercial buildings, namely Everbright Financial Center, part of Everbright International Mansion and Ming Chang Building, with a total gross floor area (“GFA”) of approximately 89,507 square meters.Property Management ServiceThe Group provides property management services for its properties, namely Everbright Financial Center and Everbright International Mansion. Revenue from the Group’s property management services was approximately RMB15.9 million for the year ended 31 December 2025 (2024: RMB15.4 million). The increase in revenue from property management services was due to the increase in restaurant income. As at 31 December 2025, the total GFA under the Group’s management was 72,534 sq.m.Investment PropertiesThe Group's investment properties primarily consist of land and/or buildings which are owned or held under a leasehold interest to earn rental income and/or for capital appreciation. As at 31 December 2025, the fair value of the investment properties was RMB979.0 million (2024: RMB967.1 million), representing an increase of approximately 1.23%. For the year ended 31 December 2025, the valuation gain on investment properties amounted to approximately RMB10.3 million (2024: approximately RMB6.6 million).PROSPECTSAs the World Bank noted that despite persistent trade tensions, the global economy has demonstrated stronger-than-expected resilience. Amid a complex environment of mounting external pressures and internal challenges, China continued to advance high-quality development, with the overall economy maintaining stable performance and achieving steady progress. With stable economic growth, corporate demand for commercial space has increased. Coupled with accelerated urbanization and the development of new business districts, demand for commercial properties has continued to rise, supporting the growth of commercial property management and leasing activities. In addition, the Chinese government has introduced a series of favourable policies for the commercial real estate sector, focusing on inventory digestion and optimization of industry planning, thereby providing further support to the property management and leasing industry.The Group’s managed properties mainly comprise commercial assets. Despite macroeconomic conditions and market competition, tenancy arrangements, lease agreements and occupancy rates remained stable in 2025. However, rental levels for newly signed leases were lower than in previous periods. To mitigate the pressure arising from rental adjustments, the Group will continue to enhance customer satisfaction by incorporating value-added services into new lease agreements, including property maintenance and upkeep, facilities management and community event planning.The Group’s existing properties are primarily located in Chengdu, Sichuan and Kunming, Yunnan—two key regional cities—and comprise three commercial buildings: Everbright Financial Center, Everbright International Mansion and Ming Chang Building. Benefiting from their prime locations and high-quality facilities, these properties have attracted a sizable number of state-owned enterprises and large institutions, providing a solid foundation for the Group’s leasing business. In recent years, the Group has successfully introduced tenants from emerging sectors such as software and technology, while also offering digitalised services to tenants. Looking ahead, the Group will continue to promote diversified business development and strive to attract more high-quality commercial tenants.In addition, the further escalation of the situation in the Middle East in March 2026 has led to rising energy prices, heightened inflation expectations and slower economic growth, all of which are core factors affecting overseas investment decisions. Accordingly, the Group will carefully reassess its asset allocation and regional risks with respect to its overseas investment plans. Despite the current significant volatility in the global economy, the Group will adhere to the principle of prudent operation, flexibly seize investment windows, and ensure the safety of capital operations.The Group continues to leverage technology to advance smart property management, enhance operational efficiency and elevate the customer experience. By strengthening digitalisation and refined management capabilities, the Group aims to further improve service quality and customer satisfaction.By fully leveraging the synergy with its parent company, China Everbright Group, while actively developing diversified value-added services to broaden its revenue mix and enhance brand influence. As the industry undergoes transformation and upgrading, the Group remains committed to prudent operations, a strong focus on risk management and internal controls, agile responses to macroeconomic and policy developments, continuous optimisation of its asset portfolio, further strengthening of its resilience against market uncertainties, and also actively explore new development opportunities to create greater value for the shareholders.About Everbright Grand China Assets LimitedEverbright Grand China Assets Limited is engaged in the businesses of property leasing and the provision of property management services under China Everbright Group. It owns, leases and manages properties located in Chengdu, Sichuan province, and also owns and leases a property located in Kunming, Yunnan province. The Group's properties are located in the city centers of Chengdu and Kunming, the key cities of western China. The Group's property portfolio includes three commercial properties, namely Everbright Financial Center, part of Everbright International Mansion and Ming Chang Building. For more information about Everbright Grand China Assets, please visit the Company’s website: https://ebgca.com.hk/.This press release is issued by Porda Havas International Finance Communications Group on behalf of Everbright Grand China Assets Limited.For inquiries, please contact: Kelly Fung+852 2590 1900kelly.fung@pordahavas.co Qin Luk+852 2590 1903samantha.luk@pordahavas.comEmail: ebgca.hk@pordahavas.com Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com